SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
59.50    0.00 (0.00%)
Bid:
58.00
Ask:
61.00
Spread: 3.00 (5.172%)
Market Cap: £47.29m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

AGM Statement

15 Mar 2021 07:00

RNS Number : 1702S
Hardide PLC
15 March 2021
 

15 March 2021

 

Hardide plc

("Hardide", "the Group" or "the Company")

 

AGM Statement

 

At the Annual General Meeting of Hardide plc (AIM: HDD) to be held at 11:30am today, Robert Goddard, Chairman of the Company, will make the following statement: 

 

"The Company is in a sound financial position with new proceeds of approximately £1 million received from the recent fundraising. As expected, trading remains largely stable around the same levels experienced in the second half of last year, when the effects of the COVID-19 pandemic impacted our target market sectors. The Board expects recovery in demand, particularly from the oil and gas sector, to accelerate in H2 2021. The rise in oil prices to over $60 per barrel, the encouraging increase in the number of working oil and gas rigs in North America and the increasing global demand for oil, gives us confidence that the beginning of recovery is underway. 

 

"The new UK site is fully operational, with both sufficient capacity and capability to cope with the expected near-term resumption of customer demand. Aerospace business from Airbus, while somewhat delayed due to the effects of COVID-19, is expected to commence in late 2021. The accreditation of equipment and production processes at the new site is on schedule and due to be completed in late spring/early summer of 2021. The lease on the Wedgwood Road site ends in October 2021. The US site has continued operating normally with the new, fourth coating reactor now fully operational.

 

"The Board retains its positive outlook and expectations that demand will return and continue on the upward trajectory that was established before the pandemic. In addition, there are a number of potential high‑volume projects in development and test with aerospace, energy and precision engineering customers. As ever, all or some of these may or may not come to fruition, but each has the potential to make a significant contribution to revenue to the Group.

 

"Half year results are expected to be published on or around 20 May 2021."

 

 

Enquiries:

 

 

Hardide plc

Robert Goddard, Non-Executive Chairman

Philip Kirkham, CEO

Jackie Robinson, Communications Manager

 

Tel: +44 (0) 1869 353830

 

IFC Advisory

Graham Herring / Tim Metcalfe / Florence Chandler

 

Tel: +44 (0) 20 3934 6630

 

finnCap - Nominated Adviser and Joint Broker

Henrik Persson / Matthew Radley (corporate finance)

Richard Chambers (ECM)

 

Allenby Capital- Joint Broker

Jeremy Porter / Tony Quirke

 

Tel: +44 (0) 20 7220 0500

 

 

 

Tel: +44 (0) 20 3328 5656

Notes to editors:

Hardide develops, manufactures and applies advanced technology tungsten carbide/tungsten metal matrix coatings to a wide range of engineering components. Its patented technology is unique in combining, in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency. Customers include leading companies operating in oil and gas exploration and production, valve and pump manufacturing, precision engineering and aerospace industries.

www.hardide.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSRVFIFLIL
Date   Source Headline
18th May 20217:00 amRNSInterim Results
28th Apr 20213:16 pmRNSHolding(s) in Company
19th Mar 20213:19 pmRNSHolding(s) in Company
15th Mar 202112:06 pmRNSResult of AGM
15th Mar 20217:00 amRNSAGM Statement
25th Feb 202110:22 amRNSIssue of Options
19th Feb 20215:01 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSNotice of AGM
5th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 202110:50 amRNSResult of Fundraising
1st Feb 20217:00 amRNSProposed equity fundraising and CBILS loan
7th Dec 20207:00 amRNSPreliminary results for year ended 30 Sept 2020
23rd Sep 20207:00 amRNSPre-close Trading Update
3rd Aug 20205:24 pmRNSDirector Dealing - Correction
3rd Aug 202012:17 pmRNSDirector Dealing
23rd Jul 20207:00 amRNSResignation of Non-Executive Director
16th Jul 20207:00 amRNSTrading Update
25th Jun 20202:30 pmRNSExercise of Options
23rd Jun 20202:14 pmRNSHolding(s) in Company
17th Jun 20203:43 pmRNSChange of Registered Office
20th May 20204:37 pmRNSIssue of Options
19th May 20207:00 amRNSInterim Results
21st Apr 20207:00 amRNSQueen’s Award for Enterprise
14th Apr 20205:00 pmRNSExercise of Options
31st Mar 20207:00 amRNSTRADING UPDATE AND THE IMPACT OF COVID-19
17th Feb 202012:47 pmRNSResult of AGM
17th Feb 20207:00 amRNSAGM Statement
10th Feb 20207:00 amRNSPresenting at The Growth & Innovation Forum
27th Jan 20202:43 pmRNSHolding(s) in Company
27th Jan 20207:00 amRNSAppointment of Finance Director
21st Jan 20208:15 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSPlacing to raise £2.5 million
16th Dec 20195:22 pmRNSGrant of Options
9th Dec 20197:00 amRNSPreliminary Results
13th Nov 20197:00 amRNSHardide approved for F-35 Joint Strike Fighter
11th Nov 20197:00 amRNSPatent Award
15th Oct 20198:23 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSTrading Update
23rd Aug 20197:00 amRNSAppointment of Joint Broker
21st Aug 20197:00 amRNSOrders for three new coating reactors
12th Aug 20198:17 amRNSHardide selected for Airbus A330 wing components
8th Jul 20197:00 amRNSContract Award
28th Jun 20197:00 amRNSExercise of Options and Director Shareholdings
11th Jun 20195:00 pmRNSHolding(s) in Company
14th May 20197:00 amRNSInterim Results
14th May 20197:00 amRNSHardide selected for Airbus A380 wing components
13th Mar 20197:00 amRNSHardide Coating Extends Life of Turbine Blades
7th Mar 201911:37 amRNSHolding(s) in Company
7th Mar 201911:36 amRNSHolding(s) in Company
4th Mar 20193:16 pmRNSResult of AGM and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.